GD vs. BMY
GD (General Dynamics Corporation) and BMY (Bristol-Myers Squibb Company) are both stocks. Over the past 10 years, GD returned 12.38%/yr vs 1.00%/yr for BMY. At a 0.28 correlation, their price movements are largely independent.
Performance
GD vs. BMY - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with GD having a 7.93% return and BMY slightly higher at 8.27%. Over the past 10 years, GD has outperformed BMY with an annualized return of 12.38%, while BMY has yielded a comparatively lower 1.00% annualized return.
GD
- 1D
- 0.38%
- 1M
- 7.69%
- YTD
- 7.93%
- 6M
- 7.67%
- 1Y
- 29.63%
- 3Y*
- 21.44%
- 5Y*
- 15.92%
- 10Y*
- 12.38%
BMY
- 1D
- 0.40%
- 1M
- 0.23%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 20.57%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
GD vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GD General Dynamics Corporation | 7.93% | 30.39% | 3.52% | 7.13% | 21.69% | 43.77% | -13.14% | 14.80% | -21.34% | 19.85% |
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between GD and BMY is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 1977 | 0.28 |
Fundamentals
GD:
$98.74B
BMY:
$116.75B
GD:
$15.92
BMY:
$3.57
GD:
22.63
BMY:
16.02
GD:
2.86
BMY:
0.91
GD:
1.83
BMY:
2.40
GD:
3.79
BMY:
5.82
GD:
$53.81B
BMY:
$48.48B
GD:
$7.48B
BMY:
$33.33B
GD:
$6.26B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GD vs. BMY — Risk / Return Rank
GD
BMY
GD vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for General Dynamics Corporation (GD) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GD | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.76 | ||
| Sortino ratioReturn per unit of downside risk | +1.13 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.14 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 2.15 | 1.53 | +0.62 |
| Martin ratioReturn relative to average drawdown | 7.36 | 3.32 | +4.04 |
Loading charts...
Drawdowns
GD vs. BMY - Drawdown Comparison
The maximum GD drawdown since its inception was -75.67%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for GD and BMY.
Loading charts...
Drawdown Indicators
| GD | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.67% | -72.03% | -3.64% |
Max Drawdown (1Y)Largest decline over 1 year | -14.53% | -12.05% | -2.48% |
Max Drawdown (3Y)Largest decline over 3 years | -22.55% | -36.85% | +14.30% |
Max Drawdown (5Y)Largest decline over 5 years | -22.55% | -47.67% | +25.12% |
Max Drawdown (10Y)Largest decline over 10 years | -51.63% | -47.67% | -3.96% |
Current DrawdownCurrent decline from peak | -1.49% | -17.79% | +16.30% |
Average DrawdownAverage peak-to-trough decline | -15.60% | -22.38% | +6.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.23% | 6.34% | -2.11% |
Volatility
GD vs. BMY - Volatility Comparison
The current volatility for General Dynamics Corporation (GD) is 7.70%, while Bristol-Myers Squibb Company (BMY) has a volatility of 8.22%. This indicates that GD experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GD | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.70% | 8.22% | -0.52% |
Volatility (6M)Calculated over the trailing 6-month period | 17.78% | 18.18% | -0.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.67% | 27.08% | -5.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.54% | 24.02% | -3.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.76% | 25.29% | -2.53% |
Dividends
GD vs. BMY - Dividend Comparison
GD's dividend yield for the trailing twelve months is around 1.69%, less than BMY's 4.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
GD General Dynamics Corporation | 1.69% | 1.76% | 2.12% | 2.01% | 2.00% | 2.24% | 2.90% | 2.26% | 2.31% | 1.61% | 1.72% | 1.96% |
Financials
GD vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between General Dynamics Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GD vs. BMY - Profitability Comparison
GD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, General Dynamics Corporation reported a gross profit of 1.42B and revenue of 13.48B. Therefore, the gross margin over that period was 10.5%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
GD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, General Dynamics Corporation reported an operating income of 1.42B and revenue of 13.48B, resulting in an operating margin of 10.5%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
GD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, General Dynamics Corporation reported a net income of 1.13B and revenue of 13.48B, resulting in a net margin of 8.4%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
GD and BMY have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMY has higher volatility (8.22%) compared to GD (7.70%). In terms of maximum drawdown, GD dropped -75.67% vs BMY's -72.03%.
GD currently has the higher Sharpe Ratio (1.44 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GD and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer